Compare DexCom, Inc. (DXCM) vs Sprott Uranium Miners ETF (URNM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Sprott Uranium Miners ETF — how do they compare? DexCom, Inc. trades at $84.11 (market cap $31.86B), while Sprott Uranium Miners ETF trades at $46.5 (market cap $1.87B). The key difference: DexCom, Inc. is far larger — about 17× Sprott Uranium Miners ETF's market cap, and DexCom, Inc. is trading nearer its 52-week high, Sprott Uranium Miners ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and Sprott Uranium Miners ETF for 61 Days on average.
| DXCM | URNM | |
|---|---|---|
Market Cap | $31.86B | $1.87B |
Volume | 3,607,070 | 1,586,926 |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $92.34 | $83.99 |
52-Week Low | $54.84 | $46.09 |
Typical Hold Time | 62 Days | 61 Days |
Enterprise Value | $31.32B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $84.41, showing modest daily gains of 0.13%. The stock demonstrates strong fundamental performance with consistent earnings beats and robust revenue growth, reaching $4.66 billion in 2025. Technical indicators show a bearish short-term trend with key support at $82. The company maintains impressive profitability with 20.12% net margins and 38.49% ROE, supported by growing adoption of CGM technology in diabetes care.
DXCM presents a compelling growth story with expanding market opportunities in Type 2 diabetes care. Analyst consensus remains strongly bullish with 81% buy ratings and $95.07 price target, suggesting 13% upside. Key risks include reimbursement challenges and competitive pressures. The company's strong cash flow generation and institutional support provide solid foundation for continued growth.
URNM trades at $46.50, down 2.86% today amid bearish technical signals with 19 sell indicators versus 4 buy. The ETF faces resistance near $47 while finding support at $45-46 levels. Recent news highlights uranium's long-term growth potential driven by AI energy demand and nuclear expansion, though short-term volatility persists.
The uranium mining ETF benefits from structural supply deficits and government nuclear investments, but faces near-term price pressure. Key risks include commodity price volatility and execution challenges among constituent miners. Analyst sentiment remains mixed with bullish long-term themes offset by technical weakness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Sprott Uranium Miners ETF
URNM is a pure-play ETF that invests in the global uranium industry. It provides exposure to companies involved in the mining, exploration, and production of uranium, as well as physical uranium holdings, with top assets like Cameco, Uranium Energy Corp, and the Sprott Physical Uranium Trust.
Read more on URNM →
